|
|
Article: NJ to be US home for Bayer Schering Pharma, with 800 job cuts expected in the USA.(New Jersey)(Brief article)
- Article from:
- Pharma Marketletter
- Article date:
- November 20, 2006
CopyrightCOPYRIGHT 2006 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
As a result of its acquisition of fellow German drugmaker Schering AG (and its US subsidiary Berlex; Marketletters passim) and consolidation of their R&D activities, Bayer Healthcare has announced plans to cut more than 600 research jobs initially in the USA, plus a further 200 later, and said that New Jersey would become home to its US headquarters for pharmaceuticals.
As part of this change, research programs and activities now dispersed in various sites will be consolidated into three major sites involved in R&D (Berlin and Wuppertal in Germany and Berkeley, California, in the USA). The Berlin research group will take leadership for diagnostic imaging, ...